Cormorant Asset Management’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-107,344
| Closed | -$4.5M | – | 51 |
|
|
2024
Q3 | $4.5M | Hold |
107,344
| – | – | 0.24% | 40 |
|
|
2024
Q2 | $3.91M | Sell |
107,344
-431,370
| -80% | -$15.7M | 0.23% | 43 |
|
|
2024
Q1 | $27.4M | Sell |
538,714
-207,466
| -28% | -$10.6M | 1.2% | 28 |
|
|
2023
Q4 | $14.5M | Buy |
+746,180
| New | +$14.5M | 0.69% | 33 |
|
|
2017
Q1 | – | Sell |
-7,592
| Closed | -$2.51M | – | 77 |
|
|
2016
Q4 | $2.51M | Hold |
7,592
| – | – | 0.34% | 57 |
|
|
2016
Q3 | $2.03M | Hold |
7,592
| – | – | 0.22% | 66 |
|
|
2016
Q2 | $1.01M | Buy |
7,592
+92
| +1% | +$12.2K | 0.14% | 67 |
|
|
2016
Q1 | $1.32M | Hold |
7,500
| – | – | 0.2% | 65 |
|
|
2015
Q4 | $1.87M | Hold |
7,500
| – | – | 0.22% | 62 |
|
|
2015
Q3 | $2.11M | Sell |
7,500
-6,495
| -46% | -$1.83M | 0.34% | 58 |
|
|
2015
Q2 | $1.94M | Hold |
13,995
| – | – | 0.26% | 63 |
|
|
2015
Q1 | $2.3M | Sell |
13,995
-1,005
| -7% | -$165K | 0.36% | 56 |
|
|
2014
Q4 | $2.25M | Hold |
15,000
| – | – | 0.35% | 52 |
|
|
2014
Q3 | $2M | Hold |
15,000
| – | – | 0.41% | 50 |
|
|
2014
Q2 | $2.83M | Buy |
15,000
+2,656
| +22% | +$501K | 0.75% | 44 |
|
|
2014
Q1 | $3.14M | Buy |
+12,344
| New | +$3.14M | 0.72% | 39 |
|